现货大促销,价格低至8折起,量大更优惠,详细咨询客服
全部分类
全部分类
  • Brepocitinib (PF-06700841)
Brepocitinib (PF-06700841)的可视化放大

Brepocitinib (PF-06700841)

Brepocitinib (PF-06700841, PF-841) is a potent inhibitor of Tyk2 and Jak1 with IC50s of 23 nM, 17 nM, 77 nM for Tyk2, Jak1 and Jak2 respectively. It has appropriate in-family selectivity against JAK2 and JAK3.

原价
¥950-3250
价格
760-2600
Brepocitinib (PF-06700841)的二维码

所有产品仅用于科学研究,我们不为任何个人用途提供产品和服务

询价有惊喜,量大更优惠 点击这里给我发消息

  • 库存: 现货
可选包装 >>>
首页
  • 货号: ajci23052
  • CAS: 1883299-62-4
  • 别名: PF-841
  • 分子式: C18H21F2N7O
  • 分子量: 389.4
  • 纯度: >98%
  • 溶解度: DMSO: 78 mg/mL (200.31 mM);Water: Insoluble;Ethanol: 78 mg/mL (200.31 mM)
  • 储存: Store at -20°C
  • 库存: 现货

Background

Brepocitinib (PF-06700841, PF-841) is a potent inhibitor of Tyk2 and Jak1 with IC50s of 23 nM, 17 nM, 77 nM for Tyk2, Jak1 and Jak2 respectively. It has appropriate in-family selectivity against JAK2 and JAK3.


The pharmacokinetics of PF-06700841 are studied in Sprague-Dawley rats following intravenous and oral administration (1 and 3 mg/kg respectively) of the tosylate salt, where the compound shows a plasma clearance of 31 mL/min/kg, a volume of distribution of 2.0 L/kg, and oral bioavailability of 83%. Following the 3 mg/kg oral dose, the Cmax is 774 ng/mL and the AUC∞ is 1340 ng.h/mL. The high oral bioavailability indicates high absorption from the gut, consistent with its in vitro passive permeability properties and high solubility[1].


[1] Fensome A, et al. J Med Chem. 2018, 61(19):8597-8612.

动态评分

0.0

没有评分数据
没有评价数据
一键回到顶部
展开 收缩
安捷凯在线客服